Search - tctmd.com

Displaying 101 - 120 of 330

Sort: Relevancy | Date

News Daily News

Same Care, Same Outcomes for Women and Men After AMICS

Caitlin E. Cox

March 12, 2020

News Daily News

First Point-of-Care hs-Troponin I Assay Matches Lab-Based Tests

Caitlin E. Cox

March 10, 2020

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Conference News AHA 2019

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

Caitlin E. Cox

November 21, 2019

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

Caitlin E. Cox

November 17, 2019

News Daily News

Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms

Caitlin E. Cox

November 15, 2019

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Caitlin E. Cox

November 06, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Conference News TCT 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Caitlin E. Cox

October 04, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Daily News

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Caitlin E. Cox

July 25, 2019

News Conference News EuroPCR 2019

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Caitlin E. Cox

June 05, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Daily News

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Caitlin E. Cox

May 10, 2019

News Daily News

PCI on the Rise Among the Elderly, Who Are Reaping Survival Gains

Caitlin E. Cox

April 23, 2019

News Daily News

PCI Reduces Mortality in Elderly STEMI Patients With Cardiogenic Shock, New Data Confirm

Caitlin E. Cox

April 15, 2019

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Caitlin E. Cox

March 17, 2019

News Daily News

In-Hospital Acute MI: Despite Numerous Predictors, Solutions Remain Elusive

Caitlin E. Cox

January 18, 2019

Advertisement

Same Care, Same Outcomes for Women and Men After AMICS

First Point-of-Care hs-Troponin I Assay Matches Lab-Based Tests

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

More Adverse Events, Higher Costs With Impella: New Observational Studies

Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

PCI on the Rise Among the Elderly, Who Are Reaping Survival Gains

PCI Reduces Mortality in Elderly STEMI Patients With Cardiogenic Shock, New Data Confirm

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

In-Hospital Acute MI: Despite Numerous Predictors, Solutions Remain Elusive

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content